Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin‐activatable fibrinolysis inhibitor
Authors:
- 1 April 2010
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 8 (4) , 790-798
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Thrombin generation and fibrin clot structureBlood Reviews, 2007
- Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clotsThrombosis and Haemostasis, 2007
- Regulation of Fibrinolysis by Thrombin Activatable Fibrinolysis Inhibitor, an Unstable Carboxypeptidase B That Unites the Pathways of Coagulation and FibrinolysisArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Molecular recognition mechanisms of thrombinJournal of Thrombosis and Haemostasis, 2005
- Fibrinogen and fibrin structure and functionsJournal of Thrombosis and Haemostasis, 2005
- Rebuttal to: Effect of heparin on TAFI-dependent inhibition of fibrinolysisJournal of Thrombosis and Haemostasis, 2003
- Factor XIII: Structure, Activation, and Interactions with Fibrinogen and FibrinAnnals of the New York Academy of Sciences, 2001
- Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- A Novel Approach to Arterial ThrombolysisBlood, 1999
- Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.Journal of Clinical Investigation, 1998